|
⚲
|
| Keyboard |
| Coste Catherine
✚
|
|
|---|---|
| CIK # | 0001821432 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001821432] | |
| 4 | [0001821432] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Coste Catherine | |
| Biolife Solutions Inc | |
| Biomerica Inc | |
| Renalytix PLC | |
| Minerva Surgical Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biolife Solutions Inc BLFS
Common Stock
|
2026-02-24 | Grant | 8,170 | ||
|
Biolife Solutions Inc BLFS
Common Stock
|
2025-03-18 | Grant | 5,701 | ||
|
Biomerica Inc BMRA
Common stock
|
2024-12-13 | Grant | 85,000 | $0.31 | 26,350 |
|
Biomerica Inc BMRA
Non-qualified stock option · derivative
|
2023-12-13 | Grant | 75,000 | ||
|
Renalytix PLC RNLX
Employee Stock Option (right to buy) · derivative
|
2023-11-20 | Grant | 95,000 | $0.00 | |
|
Renalytix PLC RNLX
Employee Stock Option (right to buy) · derivative
|
2023-07-06 | Grant | 190,000 | $0.00 | |
|
Biomerica Inc BMRA
Non-qualified stock option · derivative
|
2023-04-20 | Grant | 32,000 | ||
|
Biomerica Inc BMRA
Common Stock
|
2023-01-26 | Buy | 2,190 | $2.96 | 6,482 |
|
Minerva Surgical Inc UTRS
Common Stock
|
2022-06-10 | Grant | 49,792 | $2.41 | 119,999 |
|
Biomerica Inc BRMA
Non-qualified stock option · derivative
|
2021-12-09 | Grant | 25,000 | ||
|
Biomerica Inc BMRA
Non-qualified stock option · derivative
|
2020-12-10 | Grant | 20,000 | ||
|
Biomerica Inc BMRA
Common Stock
|
2020-10-26 | Buy | 9,100 | $5.45 | 49,595 |